Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Langenbeck's archives of surgery (Print)

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00423-007-0245-7PMID 18064486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.

  2007cited by this paper
• Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.

  2007cited by this paper
• Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

  2007influential reference
• Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation

  2007cited by this paper
• Are Indoleamine-2,3-Dioxygenase Producing Human Dendritic Cells a Tool for Suppression of Allogeneic T-cell Responses?

  2007cited by this paper
• Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

  2007cited by this paper
• The immunoregulatory role of IDO-producing human dendritic cells revisited.

  2006cited by this paper
• Abatacept

  2006cited by this paper
• Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.

  2006cited by this paper
• Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

  2006cited by this paper
• 1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity1

  2006cited by this paper
• Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

  2005cited by this paper
• Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

  2005cited by this paper
• Studying the immunosuppressive role of indoleamine 2,3‐dioxygenase: tryptophan metabolites suppress rat allogeneic T‐cell responses in vitro and in vivo

  2005cited by this paper
• Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

  2005cited by this paper
• Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

  2005cited by this paper
• Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cited by this paper
• MHC class I down-regulation: tumour escape from immune surveillance? (review).

  2004cited by this paper
• Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

  2004cited by this paper
• Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

  2004cited by this paper
• Tolerance, DCs and tryptophan: much ado about IDO.

  2003cited by this paper
• Tryptophan degradation during and after gestation.

  2003cited by this paper
• Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion1

  2003cited by this paper
• Modulation of tryptophan catabolism by regulatory T cells

  2003influential reference
• The complementary roles of deletion and regulation in transplantation tolerance

  2003cited by this paper
• Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma

  2003cited by this paper
• Tryptophan and the immune response

  2003cited by this paper
• Does the immune system see tumors as foreign or self?

  2003cited by this paper
• Indoleamine 2,3‐Dioxygenase Expression in Patients with Acute Graft‐versus‐Host Disease after Allogeneic Stem Cell Transplantation and in Pregnant Women: Association with the Induction of Allogeneic Immune Tolerance?

  2003cited by this paper
• Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

  2003cited by this paper
• Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

  2002cited by this paper
• Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

  2002cited by this paper
• Natural selection of tumor variants in the generation of “tumor escape” phenotypes

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• The interaction properties of costimulatory molecules revisited.

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.

  2002cited by this paper
• Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection

  2002cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Characterisation of L‐tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles

  2001cited by this paper
• Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses.

  2001cited by this paper
• CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis

  2001cited by this paper
• Strategies for immunotherapy of cancer.

  2000cited by this paper
• The Fas counterattack: cancer as a site of immune privilege.

  1999cited by this paper
• Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.

  1999cited by this paper
• Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

  1999cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Prevention of allogeneic fetal rejection by tryptophan catabolism.

  1998cited by this paper
• Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes.

  1998cited by this paper
• Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma.

  1997cited by this paper
• Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation.

  1996cited by this paper
• Is cancer dangerous to the immune system?

  1996cited by this paper
• Quinolinic acid immunoreactive cells in the choroid plexus, leptomeninges and brain vasculature of the immune-stimulated gerbil.

  1994cited by this paper
• Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

  1992cited by this paper
• Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

  1991cited by this paper
• Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.

  1989cited by this paper
• Characteristics of interferon induced tryptophan metabolism in human cells in vitro.

  1989cited by this paper
• Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

  1984cited by this paper
• Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide.

  1978cited by this paper
• Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate.

  1975cited by this paper
• The concept of immunological surveillance.

  1970cited by this paper

• Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches

  2025cites this paper
• Cisplatin-Mediated IL-6 and IDO1 Suppression in Mesenchymal Stromal Cells: Implications for Tumor Microenvironment Modulation In Vitro

  2025cites this paper
• FloraStilbene: immunotherapy adjuvant for breast cancer

  2024cites this paper
• Indoleamine 2,3-Dioxygenase Is Dispensable for The Immunomodulatory Function of Stem Cells from Human Exfoliated Deciduous Teeth

  2016cites this paper
• Novel Treatment of Breast and Prostate Cancer , and Mesothelioma by Targeting Cancer Stem Cells

  2014cites this paper
• Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.

  2014cites this paper
• The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.

  2014cites this paper
• HIV-1 Tat Protein Induces the Production of IDO in Human Monocyte Derived-Dendritic Cells through a Direct Mechanism: Effect on T Cells Proliferation

  2013cites this paper
• Natural inhibitors of indoleamine 3,5-dioxygenase induced by interferon-gamma in human neural stem cells.

  2012cites this paper
• Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.

  2011cites this paper
• Ovarian Cancer Immunology and Immunotherapy

  2011cites this paper
• Rational design, synthesis, molecular modeling and evaluation of -carboline and 5H-indeno[1,2-c]pyridazin-5-one derivatives as potential MAO and IDO inhibitors : Conception rationnelle, synthèse, modélisation moléculaire et évaluation de dérivés -carbolines et 5H-indéno[1,2-c]pyridazin-5-ones comme

  2011cites this paper
• Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.

  2011cites this paper
• Nível de expressão tumoral da indoleamine 2,3-dioxigenase (IDO) como marcador biológico e preditor de metástase em pacientes com tumor carcinoide típico broncopulmonar

  2011cites this paper
• Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.

  2010cites this paper
• Rational design of indoleamine 2,3-dioxygenase inhibitors.

  2010cites this paper
• Control of Disease Recurrence by Tumor-Infiltrating T Cells in Ovarian Cancer

  2010cites this paper
• 1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of tregs

  2010cites this paper
• Immunoregulatory cells of the tumor microenvironment.

  2010cites this paper
• IDO and outcomes in ovarian cancer.

  2009cites this paper
• Induction of IDO by Bacille Calmette-Guérin Is Responsible for Development of Murine Depressive-Like Behavior1

  2009cites this paper
• The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer

  2009cites this paper
• Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors

  2009cites this paper
• Depressive-Like Behavior Is Responsible for Development of Murine Induction of IDO by Bacille Calmette-Guérin

  2009cites this paper
• Testing the theory of immune selection in cancers that break the rules of transplantation

  2009cites this paper
• Role of Myeloid Hypoxia-Inducible Factor-1alpha in the Tumor Microenvironment A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biology

  2008influential citation
• Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species

  2008cites this paper
• Costimulation targeting therapies in organ transplantation

  2008cites this paper
• Role of myeloid Hypoxia-Inducible Factor-1alpha in the tumor microenvironment - eScholarship

  2008cites this paper